AstraZeneca, Cambridge (United Kingdom of Great Britain & Northern Ireland)
Follow
Contributor content
Presentation
Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study
